Long-term Outcomes of Laparoscopic Sacrohysteropexy with SERATEX^® SlimSling^® Mesh: A Retrospective Case Series

Introduction and Hypothesis: Pelvic organ prolapse (POP) surgery has evolved toward minimally invasive techniques. Laparoscopic sacrohysteropexy (LSHP) is associated with reduced morbidity and lower mesh exposure risks. This study evaluates the long-term outcomes of LSHP using the SERATEX^® SlimSling^® mesh for isolated uterine prolapse. Methods: A retrospective case series was conducted on patients who underwent LSHP with SERATEX^® SlimSling^® mesh for apical prolapse with uterine preservation between 2014 and 2020. Data were extracted from medical records, including demographics, intraoperative details, and postoperative outcomes. Modified POP-Q measurements (Ba, Bp, C, D) were recorded. Patients were assessed perioperatively and at multiple postoperative intervals, with follow-up via telephone interviews by a urogynecologist. Statistical analysis included descriptive statistics and univariate analysis, with a p value of less than 0.05 considered significant. Results: Twenty-five women underwent LSHP with a mean age of 46 years. Most patients had isolated apical prolapse without other symptoms. Intraoperatively, 75% had concomitant cervical shortening, 10% had anterior colporrhaphy, and 30% had mid urethral sling, with a mean surgery duration of 112 min and no postoperative complications. Median follow-up was 66 months. Three patients (12%) experienced prolapse recurrence, mainly cystocele with two requiring reoperations. Four patients conceived and delivered post-procedure, all via cesarean section. At the long-term telephone interview, 76.2% were very happy with the surgery, 14.3% happy, and 9.5% unhappy. Conclusions: LSHP with the SERATEX^® SlimSling^® mesh for isolated uterine prolapse demonstrates a fair safety profile, durable outcomes, high patient satisfaction, and favorable pregnancy outcomes. This procedure offers a viable, minimally invasive option for uterine preservation.